P2RY6+ tumor-associated macrophages as a therapeutic target: suppressing tumor growth and enhancing chemosensitivity in triple-negative breast cancer
Cellular Oncology · 06.06.2026 · 49 (4)
DOI: 10.1007/s13402-026-01239-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 06.06.2026. Verfasst von Xin Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun City, Jilin Province, 130021, P.R. China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Tumor-Associated Macrophages, Receptors, Purinergic P2, Drug Resistance, Neoplasm. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun City, Jilin Province, 130021, P.R. China.
- Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun City, Jilin Province, 130021, P.R. China. han_bing@jlu.edu.cn.
Zitieren
APA
Wang, X., Ma, M., Zhang, M., Lu, H., Liu, Y., Zhou, Y., & Han, B. (2026). P2RY6+ tumor-associated macrophages as a therapeutic target: suppressing tumor growth and enhancing chemosensitivity in triple-negative breast cancer. Cellular Oncology, 49(4). https://doi.org/10.1007/s13402-026-01239-w
Vancouver
Wang X, Ma M, Zhang M, Lu H, Liu Y, Zhou Y, et al. P2RY6+ tumor-associated macrophages as a therapeutic target: suppressing tumor growth and enhancing chemosensitivity in triple-negative breast cancer. Cellular Oncology. 2026;49(4). doi:10.1007/s13402-026-01239-w
BibTeX
@article{Wang2026,
author = {Wang, Xin and Ma, Mingyue and Zhang, Mingyu and Lu, Han and Liu, Ying and Zhou, Yang and Han, Bing},
title = {P2RY6+ tumor-associated macrophages as a therapeutic target: suppressing tumor growth and enhancing chemosensitivity in triple-negative breast cancer},
journal = {Cellular Oncology},
year = {2026},
volume = {49},
number = {4},
doi = {10.1007/s13402-026-01239-w}
}
EUVIMED